Our Research Programs
Affiliated with The Warren Alpert Medical School of Brown University, Butler Hospital’s clinical research trials provide valuable information on brain-based diseases. Through our research, new treatments are being discovered for diseases including depression and anxiety, obsessive-compulsive disorder (OCD), Alzheimer’s disease, Movement Disorders, such as Parkinson’s disease, and addictions.
Butler Hospital is affiliated with the Norman Prince Neurosciences Institute, dedicated to advancing the neurosciences and reducing human suffering from disorders of the nervous system through world-class research, outstanding clinical care and advanced education.
As a result, people with these life-altering illnesses are finding relief and helping develop innovative treatments.
To learn more about the research being conducted at Butler Hospital, please call (401) 455-6220 or 1-800-433-6888 (in RI) or 1-800-272-9699 (outside of RI).
Learn more about Butler Hospital's research relating to mood disorders, obsessive-compulsive disorders, memory disorders, movement disorders as well as other studies researching aspects of mental health. Follow the links below to view current studies.
Parkinson’s Disease and Other Movement Disorders
Research is a major component of Butler Hospital’s Movements Disorders Program. In addition to researching the sensory motor symptoms, the behavioral aspects of Parkinson's disease, such as the depression, apathy and fatigue are being studied through multicenter trials sponsored by the National Institutes of Health and the Michael J. Fox Foundation.
Obsessive-Compulsive Disorder (OCD)
Butler was one of few hospitals in the country to conduct research using deep brain stimulation (DBS) to treat OCD. DBS for the treatment of OCD received the Federal Food and Drug Administration’s approval in 2008.
Alzheimer's Disease and Memory Disorders
Research at Butler Hospital is helping to identify the causes of Alzheimer’s disease and other disorders that affect memory, such as normal pressure hydrocephalus (NPH). This research is leading to the discovery of new treatments that will limit the progression of these illnesses, as well as prevent onset.